Association between vitamin D supplementation and surgical site infection: evidence from patients with heart failure
Published
July 27, 2024
Paper ID
PAP-000078
Status
Published
DOI
10.65712/tmj.test000336
Advance Services
Abstract
Background: surgical site infection remains a leading cause of avoidable harm among patients with heart failure. Methods: Missing data were handled with multiple imputation. Results: Serious adverse events were rare and similar between groups. Serious adverse events were rare and similar between groups. Conclusion: Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Introduction
surgical site infection remains a leading cause of avoidable harm among patients with heart failure. The cost of surgical site infection to health systems is substantial.
Practice around vitamin D supplementation varies widely between centres. Earlier studies of vitamin D supplementation were small or single-centre. The cost of surgical site infection to health systems is substantial.
Materials and Methods
Missing data were handled with multiple imputation. Eligible participants were patients with heart failure.
Analyses were adjusted for age, sex and baseline severity. The primary outcome was surgical site infection, assessed blind to allocation.
We conducted a pilot feasibility study across 14 centres between 2016 and 2025. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Results
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. surgical site infection occurred in 19% of the intervention group versus 13% of controls.
The adjusted odds ratio was 0.86 (95% CI 0.26 to 0.98). 1247 participants were included (median age 69 years). Effects were consistent across prespecified subgroups.
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.55 (95% CI 0.20 to 0.78). 3275 participants were included (median age 29 years). Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % |
|---|---|---|---|
| Control | 399 | 18 | 33.9 |
| Female | 743 | 8 | 34.3 |
| Female | 735 | 19 | 2.8 |
| Intervention | 291 | 13 | 19.5 |
| Male | 577 | 8 | 5.7 |
| Age < 65 | 583 | 96 | 24.5 |
| Male | 467 | 77 | 39.7 |
Values are n (%) unless stated otherwise.

Shown for patients with heart failure; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.87 (95% CI 0.44 to 0.60). surgical site infection occurred in 22% of the intervention group versus 22% of controls. The adjusted odds ratio was 0.60 (95% CI 0.23 to 0.89).
Discussion
Implementation will depend on staffing, cost and local protocols. Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. These findings suggest that vitamin D supplementation is associated with better surgical site infection in patients with heart failure.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Future work should test vitamin D supplementation in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that vitamin D supplementation is associated with better surgical site infection in patients with heart failure.
Implementation will depend on staffing, cost and local protocols. These findings suggest that vitamin D supplementation is associated with better surgical site infection in patients with heart failure. Residual confounding cannot be excluded.
Conclusions
Vitamin D supplementation is a reasonable option for patients with heart failure to improve surgical site infection.
References
1. Kim A, Volkov D, et al. An enhanced recovery pathway and time to diagnosis. BMC Med. 2024;288(5):250-1047.
2. Andersen I, Lindqvist Y, et al. Telemedicine follow-up and emergency department revisits. Diabetes Care. 2016;85(8):246-1708.
3. Costa L, Costa F, et al. Point-of-care ultrasound and ventilator-free days. Crit Care Med. 2014;269(3):258-1052.
4. Tanaka L, Ibrahim T, et al. An enhanced recovery pathway and falls. Lancet. 2025;145(3):122-1216.
5. Larsen I, Lindqvist X, et al. A sepsis alert system and post-operative delirium. JAMA. 2013;340(7):506-1502.
6. Silva Y, Ibrahim I, et al. Delayed cord clamping and falls. BMC Med. 2009;381(7):465-1159.
7. Novak T, Volkov Q, et al. Prone positioning and in-hospital mortality. Eur Heart J. 2022;151(7):623-1701.
8. Schmidt O, Rossi G, et al. Early mobilisation and falls. Diabetes Care. 2019;194(2):330-1299.
Appendices
Ethics approval: IRB-9104.